IT1244743B - Medicamento per il trattamento della dermatite - Google Patents

Medicamento per il trattamento della dermatite

Info

Publication number
IT1244743B
IT1244743B ITMI910381A ITMI910381A IT1244743B IT 1244743 B IT1244743 B IT 1244743B IT MI910381 A ITMI910381 A IT MI910381A IT MI910381 A ITMI910381 A IT MI910381A IT 1244743 B IT1244743 B IT 1244743B
Authority
IT
Italy
Prior art keywords
treatment
dermatitis
klebsiella
medication
catarrhalis
Prior art date
Application number
ITMI910381A
Other languages
English (en)
Italian (it)
Inventor
Courten Alfred De
Jean-Claude Farine
Original Assignee
Om Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Om Lab Sa filed Critical Om Lab Sa
Publication of ITMI910381A0 publication Critical patent/ITMI910381A0/it
Publication of ITMI910381A1 publication Critical patent/ITMI910381A1/it
Application granted granted Critical
Publication of IT1244743B publication Critical patent/IT1244743B/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ITMI910381A 1990-02-16 1991-02-14 Medicamento per il trattamento della dermatite IT1244743B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH497/90A CH680045A5 (enrdf_load_stackoverflow) 1990-02-16 1990-02-16

Publications (3)

Publication Number Publication Date
ITMI910381A0 ITMI910381A0 (it) 1991-02-14
ITMI910381A1 ITMI910381A1 (it) 1992-08-14
IT1244743B true IT1244743B (it) 1994-08-08

Family

ID=4188357

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI910381A IT1244743B (it) 1990-02-16 1991-02-14 Medicamento per il trattamento della dermatite

Country Status (13)

Country Link
JP (1) JP3002552B2 (enrdf_load_stackoverflow)
KR (1) KR0169982B1 (enrdf_load_stackoverflow)
AT (1) AT402152B (enrdf_load_stackoverflow)
BE (1) BE1005589A3 (enrdf_load_stackoverflow)
CH (1) CH680045A5 (enrdf_load_stackoverflow)
DE (1) DE4104728C2 (enrdf_load_stackoverflow)
EG (1) EG19540A (enrdf_load_stackoverflow)
FR (1) FR2658419B1 (enrdf_load_stackoverflow)
GB (1) GB2240922A (enrdf_load_stackoverflow)
HU (1) HU210834B (enrdf_load_stackoverflow)
IT (1) IT1244743B (enrdf_load_stackoverflow)
PL (1) PL289084A1 (enrdf_load_stackoverflow)
PT (1) PT96789B (enrdf_load_stackoverflow)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2098109C1 (ru) * 1996-09-26 1997-12-10 Александр Григорьевич Чучалин Противоаллергическое, противовоспалительное средство, способ его получения, лечебное и косметическое средства с его использованием
WO1999048510A1 (fr) * 1998-03-24 1999-09-30 Tayca Corporation Inhibiteur de la production d'anticorps d'immunoglobuline m et medicament contre la polyarthrite rhumatoide
WO2004112833A1 (en) 2003-06-23 2004-12-29 Biotech Tools Sa Epitope composition for sublingual, buccal or enteric administration prepared by hydrolysis of antigenic structures with chymotrypsin
UA72065C2 (en) * 2004-09-10 2005-01-17 Viridans Ltd Liability Company Strain aerococcus viridans 167k imb b-7069 with antibacterial activity and "viabac" preparation comprising this strain
FR2969657B1 (fr) * 2010-12-22 2014-02-07 Fabre Pierre Dermo Cosmetique Nouvelle bacterie et extraits de ladite bacterie et leur utilisation en dermatologie
GB201318170D0 (en) * 2013-10-14 2013-11-27 Univ Edinburgh Proteins with Diagnostic and Therapeutic Uses
WO2020218868A1 (ko) * 2019-04-26 2020-10-29 주식회사 엠디헬스케어 스트렙토코커스 파이오제네스 세균 유래 단백질 및 이의 용도
KR102437436B1 (ko) 2019-04-26 2022-08-30 주식회사 엠디헬스케어 스트렙토코커스 파이오제네스 세균 유래 단백질 및 이의 용도

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH633188A5 (fr) * 1978-05-26 1982-11-30 Om Laboratoires Sa Medicament contre des maladies infectieuses des voies respiratoires.

Also Published As

Publication number Publication date
FR2658419B1 (fr) 1995-01-27
JPH04211017A (ja) 1992-08-03
DE4104728C2 (de) 1999-01-14
CH680045A5 (enrdf_load_stackoverflow) 1992-06-15
AT402152B (de) 1997-02-25
PT96789B (pt) 1998-08-31
HU910511D0 (en) 1991-09-30
BE1005589A3 (fr) 1993-11-16
JP3002552B2 (ja) 2000-01-24
ITMI910381A0 (it) 1991-02-14
GB9103278D0 (en) 1991-04-03
GB2240922A (en) 1991-08-21
DE4104728A1 (de) 1991-08-22
PT96789A (pt) 1991-10-31
KR0169982B1 (ko) 1999-02-01
KR910015306A (ko) 1991-09-30
ATA32291A (de) 1996-07-15
PL289084A1 (en) 1991-11-04
HU210834B (en) 1995-08-28
HUT61201A (en) 1992-12-28
FR2658419A1 (fr) 1991-08-23
ITMI910381A1 (it) 1992-08-14
EG19540A (en) 1995-08-30

Similar Documents

Publication Publication Date Title
Manders Toxin-mediated streptococcal and staphylococcal disease
DE69527195D1 (de) Anti gram positive bakterielle verfahren und mittel
EP0665754A4 (en) ANTIMICROBIAL POLYPEPTIDES.
IT1244743B (it) Medicamento per il trattamento della dermatite
Gill et al. Changing patterns of bacterial resistance to antimicrobial drugs
Phillips et al. In-vitro comparison of erythromycin, lincomycin, and clindamycin
Segev et al. Double-blind randomized study of 1 g versus 2 g intravenous ceftriaxone daily in the therapy of community-acquired infections
ATE182470T1 (de) Multimeres alpha-lactalbumin enthaltende antibakterielle zusammensetzung
Lorenz Comparison of 5-day and 10-day cefixime in the treatment of acute exacerbation of chronic bronchitis.
Ginsburg Streptococcus.
Bernard et al. In Vivo Selection of Streptococcus pneumoniae, Resistant to Quinolones, Including Sparfloxin
Anzueto et al. Safety and efficacy of clarithromycin vs cefuroxime axetil in the treatment of acute bacterial exacerbation of chronic bronchitis.
Uezumi et al. Effects of a human antiflagellar monoclonal antibody in combination with antibiotics on Pseudomonas aeruginosa infection
Calandra Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer patients.
Perkins et al. Cephaloglycin: crossover absorption studies and clinical evaluation
Ling et al. Antimicrobial resistance of clinical isolates from 1987 to 1993 in Hong Kong
Appelbaum et al. Septicemia due to Streptococcus equisimilis in a child with acute lymphoblastic leukemia
D'Antonio et al. Comparison of norfloxacin and pefloxacin in the prophylaxis of bacterial infection in neutropenic cancer patients
Neu New strategies for the 1990's: antibacterial therapy
JP2004507440A5 (enrdf_load_stackoverflow)
ES8707251A1 (es) Un metodo para producir n-desacetil-antibiotico tan-588
Ryabichenko et al. Inhibition of bactericidal activity of mouse peritoneal macrophages under combined use of staphylococcal enterotoxin type A and endotoxin.
Feder Jr et al. Group A streptococcal multifocal septic arthritis: a case report
FI864769L (fi) Icke-adjuvanserad vaccin.
Sugita et al. Clinical efficacy in pediatrics sinusitis infections of cefditoren pivoxil granule therapy and its in vitro antibacterial activity against clinically isolated strains

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19960209